Full Length Research Paper
References
|
American Provers ((1859)). Union Provings of Cannabis Indica. Forgotten books (Classic Reprint). The American Provers' Union. FB & C Limited, London, UK |
|
|
Bauschke R (2010). Defining regulation: review of previous theory. The effectiveness of European regulatory governance: the case of pharmaceutical regulation. Heidelberg: Ruprecht-Karls-Universität Heildelberg,Thesis pp. 58-60. |
|
|
Bilbao A, Spangal R (2022). Medical cannabinoids: a pharmacology=based systematic review and meta-analysis for all relevant medical indications. BMC Medicine 20:259. |
|
|
Birch BE (1889). The use of Indian hemp in the treatment of chronic chloral and chronic opium poisoning. The Lancet 133(3422):625. Originally published as 1 (3422) |
|
|
Booth M (2003). Cannabis, a history. New York: Picador p 134:351-331 |
|
|
Bridgeman MB, Abazia DT (2017). Medicinal cannabis: History, Pharmacology, and Implications for the Acute Care Setting. Journal of Pharmacy and Therapeutics 42(3):180-188. |
|
|
Callréus T (2005). The precautionary principle and pharmaceutical risk management. Drug Safety 28(6):465-471. |
|
|
Callréus T, Schneider CK (2013). The emergence of regulatory science in pharmaceutical medicine. Journal of Pharmaceutical Medicine 27:345-351. |
|
|
Clarke RC, Merlin MD (2016). Cannabis domestication, breeding history, present-day genetic diversity, future prospects. Critical Review in Plant Science 35:293-327. |
|
|
Deardorff D, Wadsworth K (2017). What's wrong with my marijuana plant. A Cannabis grower's visual guide to easy diagnosis and organic remedies. Ten Speed press, California. New York. p. 2. |
|
|
Dixon WE (1899) The action of some new preparations from Cannabis Indica. British Medical Journal 2:1517. |
|
|
European Medicines Agency (2011) Road Map to 2015 [online]. |
|
|
Europenews (2022). Cannabis has gone on sale in Switzerland as part of study into regulation. |
|
|
Food and Drug Administration (FDA) (2019) Adaptive designs for clinical trials for drugs and biologics. |
|
|
Francis JG (1993). Introduction: The politics of regulation: a comparative perspective. Oxford: Blackwell pp. 1-5 |
|
|
Hodges C., Bhatarah P, Gibbs B (2022). The Hodges Review: From containment to nurturing. Hodgesreview.com |
|
|
Huestis MA (2007) Human cannabinoid pharmacokinetics. Chemistry and Biodiversity 4:1770-1804. |
|
|
Johner C (2020) Regulatory Science: Europe is Flying Blind. |
|
|
Institute of Medicine (2012) Strengthening a workforce for innovative regulatory science in therapeutics development: Workshop summary. Washington DC: The National Academic Press pp. 19-30 |
|
|
Lewis MA, Russo EB, Smith KM (2018) Pharmacological foundations of Cannabis chemovars. Planta Medica 84(4):225-233. |
|
|
Kahn J (2021). International- Cannabis Industry. Can weed give Africa's economies a buzz. Fortune. June 2, 2021 |
|
|
Mahajan R, Gupta K (2010). Adaptive design clinical trials: Methodology, challenges and prospect. Indian Journal of Pharamcology 42(4):201-207. |
|
|
Martin JH, Hill C, Walsh A, Efron D, Taylor K, Kennedy M, Galletis R, Lightfoot P, Hanson H, Agar M, Lacey J (2020). Clinical trial with cannabis medicines - guidance fot ethics committees, governance officers and researchers to streamline ethics apllications and ensuring patient safety: considerations from Australian experiene. Trial 21:932 |
|
|
McPartland JM, Guy GW (2017). Models of cannabis taxonomy, cultural bias and conflicts between scientific and vernacular names. Botanic Review 83:327-381. |
|
|
Moschick EC, Mercado C, Yoshino T, Mutsuura K, Watanabe K (2012) Usage and attitude of physicians in Japan concerning traditional Japanese medicine (Kampo): A descriptive evaluation of representative questionnaire-based survey. Evidence-Based Complementary and Alternative Medicine 2012:139818. |
|
|
Ncube BM, Dube A, Ward K (2021) Establishment of the African Medicines Agency: Progress, challenges and regulatory readiness. Journal of Pharmacy Policy and Practice 14(29):1-12. |
|
|
Nutt D, Bazure S, Phillips LD, Schlag AK (2020) So near yet so far: why wont the UK prescribe medicinal cannabis. British Medical Journal Open 10:e038687. |
|
|
Putri D (2020). Cannabis rescheduling: What could it mean for Africa?. Briefing paper. International Drug Policy Consortium and Transnational Institute. |
|
|
Piomelli D, Russo EB (2015). The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo. Cannabis Cannabinoid Research 1:44-46. |
|
|
Prohibition Partners (2022). Africa cannabis market could be worth over $US7.1 billion annually by 2023. The African Cannabis Report. Prohitionpartners.com 21.03.2019 |
|
|
Reddy V, Grogan D, Ahluwalia M, Salles EL, Ahluwalia P, Khodadadi H, Alverson K, Nguyen A, Raju SP, Braun M, Vale FL, Costigliola V, Dhandapuni K, Baban B, Vaibhav K (2020).Targeting the endocannabinoid system: A predictive, preventive and personalize medicine-directed approach to the management of brain pathologies. EPMA Journal 11(2):217-250 |
|
|
Russo EB (2019). The case for the entourage effect and conventional breeding of chemical cannabis: No "Strain" no Gain. Frontiers in Plant Science 9:1969. |
|
|
Sabaghi D (2022). Inside The Largest Ever Independent Cannabis Study In The UK forbes. |
|
|
South Africa Health Products Regulatory Authority (SAHPRA) (2020). The innovation in regulatory science capacity development in Africa, virtual meeting report. 30 June, 2020. |
|
|
Schoedel KA, Chen N, Hilliard A, White L, Scot C, Russo E, Wright S, Guy G, Romach MK, Sellers EM (2011). A randomized double-blind placebo-controlled crossover to evaluate the subjective abuse potential and cognitive effects nabiximols oromucosal spray in subjects with a history of recreational cannabis use. Human Psychopharmacology 26(3):224-236. |
|
|
Semete-Makokotlela B, Mahlangu GN, Mukanga D, Darko DM, Stonier P, Gwaza L, Nkambule P, Matsoso P, Lehnet R, Rosenkranz B, Pillai GC (2022). Needs-driven talent and competency development for the next generation of regulatory scientist in Africa. British Journal of Clinical Pharmacology 88(2):579-586 |
|
|
Small E (2015). Evolution and classification of Cannabis sativa (marijuana hemp) in human utilization. Botanical Review 81:189-294. |
|
|
Tashkin DP (2017) Effects marijuana smoking on the lung. Annals of the American Thoracic Society 13:239-247. |
|
|
Tashkin DP, Roth M (2020). Impact of marijuana smoking on lung function in older persons. European Respiration Journal 55:1902328 |
|
|
US FDA (2016). Botanical Drug Development Guidance for Industry. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
